Journalartikel
Autorenliste: Naber, Kurt G.; Wullt, Bjorn; Wagenlehner, Florian M. E.
Jahr der Veröffentlichung: 2011
Seiten: 21-35
Zeitschrift: International Journal of Antimicrobial Agents
Bandnummer: 38
ISSN: 0924-8579
eISSN: 1872-7913
DOI Link: https://doi.org/10.1016/j.ijantimicag.2011.09.003
Verlag: Elsevier
Abstract:
Uncomplicated urinary tract infections (UTIs) in otherwise healthy premenopausal women are one of the most frequent infections in the community. Therefore any improvement in management will have a high impact not only on the quality of life of the individual patient but also on the health system. In placebo-controlled studies antimicrobial treatment was significantly more effective than placebo, but on the other hand showed more adverse events. The choice of antibiotic depends on the spectrum and susceptibility patterns of the uropathogens, its effectiveness for this indication, its tolerability, its collateral effects and cost. After a systematic literature search, recommendations for empiric treatment of acute uncomplicated cystitis and acute uncomplicated pyelonephritis and for follow-up strategies were developed. (C) 2011 Elsevier B. V. and the International Society of Chemotherapy. All rights reserved.
Zitierstile
Harvard-Zitierstil: Naber, K., Wullt, B. and Wagenlehner, F. (2011) Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women, International Journal of Antimicrobial Agents, 38, pp. 21-35. https://doi.org/10.1016/j.ijantimicag.2011.09.003
APA-Zitierstil: Naber, K., Wullt, B., & Wagenlehner, F. (2011). Antibiotic treatment of uncomplicated urinary tract infection in premenopausal women. International Journal of Antimicrobial Agents. 38, 21-35. https://doi.org/10.1016/j.ijantimicag.2011.09.003
Schlagwörter
400 MG; Acute cystitis; ACUTE PYELONEPHRITIS; Aminoglycosides; AMOXICILLIN; antimicrobial susceptibility; Cefpodoxime; CEPHALOSPORINS; Cotrimoxazole; Cystitis; DOUBLE-BLIND; Empiric therapy; EXTENDED-RELEASE CIPROFLOXACIN; fosfomycin; LEVOFLOXACIN; nitrofurantoin; Ofloxacin; Pivmecillinam; PREMENOPAUSAL WOMEN; SHORT-TERM TREATMENT; SINGLE-DOSE FOSFOMYCIN; TRIMETHOPRIM-SULFAMETHOXAZOLE; TROMETAMOL MONURIL(R); Uncomplicated urinary tract infection